Le Lézard
Classified in: Health, Business
Subject: FNC

Contemporary Medical Apparel Leader Jaanuu Closes Investment Round With Executives Behind Amazon, Nordstrom, Guthy-Renker & Others


EL SEGUNDO, Calif., Nov. 29, 2017 /PRNewswire/ -- Jaanuu, the contemporary, runway-inspired medical apparel company that is disrupting the multi-billion-dollar medical apparel market, has finalized a new strategic investment round, Founder and CEO Shaan Sethi announced today. The additional financing will support significant growth plans for 2018, including expansion into new apparel categories and senior level staffing hires. The lifestyle brand was launched in 2013 by private equity investor Sethi together with his sister, Dr. Neela Sethi Young.

Jaanuu has assembled a stellar powerhouse group of fashion and tech savvy investors including Dan Nordstrom (former co-president of Nordstrom) and his Nordstrom family, Joel Spiegel, former VP of engineering for Amazon and creator of Amazon Marketplace, Georg Richter, former president and COO of Guthy-Renker, Gabriel Naouri, deputy head of international operations of Groupe Casino, Innovation Global Capital, Maywic Select Investments and others, some of whom served as early investors in the venture.

Introduced four years ago with its fresh vision of contemporary, fashionable scrubs, lab coats and footwear, Jaanuu has become the most successful and fastest growing direct-to-consumer brand in the medical apparel space. The company parlayed a modest capital investment into exponential growth by harnessing early feedback from loyal consumers via social media, input from medical colleagues nationwide, and a data-driven business model. The company's robust growth metrics verify its success, with appx. 2500% revenue growth over the last two years, a $120 average order value (AOV) per customer, and strong repeat business, with 50% of its monthly orders emanating from existing customers.

"I've been impressed with how quickly Jaanuu has become the leader in this large and underserved apparel segment," said Dan Nordstrom. "Over many decades in the business I've learned that customers quickly recognize and respond to superior quality and design.  And it's clear that today's consumer is also looking for brands that align with their personal values.  Jaanuu is delivering on all fronts."

"It excites me to see a company like Jaanuu that is using technology to create an exceptional customer experience and product, especially for healthcare professionals who are passionate and deserving," said Joel Spiegel.

"From day one, we have been focused on generating a venture-trajectory growth for Jaanuu, and the investor group in this capital round genuinely supports this strategic vision," said Jaanuu CEO Shaan Sethi.  "With the support of our strategic investors, we look forward to taking the company to the next level in 2018."

About Jaanuu
Launched in 2013, Jaanuu is the leader in contemporary medical workwear, runway-inspired scrubs, lab coats and footwear reflecting some of today's most popular fashion trends.  Jaanuu transformed the market upon its launch in 2013 as a direct-to-consumer brand embracing the mission to help professional women look their best and feel confident.  Along with its fashion-forward styles, Jaanuu is also distinguished by its proprietary fabrication Jaanaceatm, which incorporates moisture-wicking Tencel, anti-odor protection, premium antimicrobial-finished fabric to restrict the growth of bacteria, and a pioneering four-fabric stretch blend manufactured to stay soft and wrinkle resistant in harsh hospital conditions.  Visit the website: www.jaanuu.com.  Follow on Facebook, Instagram, Twitter and Pinterest.

SOURCE Jaanuu


These press releases may also interest you

at 20:31
Fitness International, LLC opened a new Club Studio location in Kingwood, Texas. The new 40,000 square foot club features five innovative boutique fitness studios that were carefully curated to create a unique experience, along with recovery services...

at 19:35
Mirum Pharmaceuticals, Inc. today announced that on May 10, 2024, the Compensation Committee of Mirum's Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 38,600 shares of common stock and 19,300...

at 19:00
Evolus, Inc. , a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported the grant of non-qualified stock options to purchase an aggregate of 10,990 shares of Evolus and an aggregate of 42,759...

at 18:36
Inhibrx, Inc. ("Inhibrx," or the "Company") today announced that in connection with the previously announced distribution by the Company of 92% of shares of common stock of its subsidiary Inhibrx Biosciences, Inc. ("SpinCo") to holders of shares of...

at 17:55
Asia Green Biotechnology Corp. ("Asia Green" or the "Company") announces that, further to its news releases dated April 17, 2024, April 26, 2024, and May 8, 2024, the Management Cease Trade Order ("MCTO") issued by the...

at 17:53
The following statement is being issued by Rice Harbut Elliott LLP regarding the Ruckman v. Biotrade Canada Ltd. et al. lawsuit: All persons in Canada who purchased or ingested U-Dream on or after August 18, 2014 (the "Class" or "Class Members")...



News published on and distributed by: